Lacidofil

A unique combination, 26 clinical studies

An increasing level of evidence in GUT-RELATED fields and paving the way for new applications beyond the gut

A specific probiotic formula combining:

  • L. rhamnosus Rosell®-11
  • L. helveticus Rosell®-52

Commercially available since 1995 with a pharmacovigilance program showing safe use.

Now marketed under various registrations status in more than 20 countries incl. USA, Canada, France, UK, Poland, S. Korea…

An extensive documentation on single strains and consistent in vivo results on the combination.

Supported by 26 CLINICAL STUDIES,  13 in children / 13 in adults (incl. 2 in pregnant women): 1,700+ participants enrolled.